
Everlight shifts global teleradiology stack to RadOS
The 5-year agreement will put Sirona Medical’s cloud-native platform across Everlight’s operations in 6 markets, covering PACS, reporting, worklist, archive, and AI workflows.
Section
M&A, vendor news, reimbursement, and the economics of imaging.

The 5-year agreement will put Sirona Medical’s cloud-native platform across Everlight’s operations in 6 markets, covering PACS, reporting, worklist, archive, and AI workflows.

HCA Healthcare agreed to acquire CHCP, a Texas allied-health education provider that owns MTMI and offers programs in sonography, radiologic technology, and medical coding.

Siemens Healthineers and Cercare Medical are pairing Syngo DynaCT Multiphase with Neurosuite to support perfusion imaging during acute stroke interventions.

Captive Radiology said the investment will help scale turnkey imaging programs as demand grows for PET-CT, MRI, and theranostics-related services.

Version 8.9.0 is scheduled for June 2026 through aycan and will add support for pathology workflows and saving reconstructed MPR viewports as new study series.

DOSIsoft Theranostics will operate within the DOSIsoft group, with its own partnerships and investment strategy centered on PLANET software.

Mevion said the S250-FIT installation would be Vietnam’s first proton therapy system, with operation expected as early as late 2027 at Tam Anh’s Phu My Hung facility.

Jardine Matheson will acquire 100% of I-MED Radiology Network in a deal valued at A$3.4B, including I-MED’s minority stake in Harrison.ai.

FTSE Russell’s preliminary June reconstitution list includes Hyperfine, with index changes set to take effect after U.S. markets close on June 26.

Lantheus is weighing a potential sale after an approach from Curium Pharma, while company filings show recent Pylarify pressure and pending PET regulatory milestones.

The agreement covers nordicMEDiVA, nordicAktiva, selected MRI hardware, and patient comfort products across authorized global markets.

Carole Bloodgood’s donation will help Hancock Health Foundation fund a permanent on-site PET/CT scanner as demand has risen 60% over 3 years.

The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.

The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.

The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.